ELISA Analyzer Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 2.30 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
ELISA Analyzer Market Analysis
The ELISA analyzer market is expected to register a CAGR of 2.3% over the forecast period, 2022-2027.
COVID-19 has had both positive and negative impacts on the market studied. For instance, the demand for ELISA analyzers for COVID-19 testing increased during the pandemic. The rise in demand for ELISA testing in the detection of COVID-19 fueled the growth of the market in the later phase of the pandemic. In addition, various in vitro diagnostic companies launched ELISA test kits for the detection of COVID-19 which required the use of ELISA analyzers. For instance, in August 2021, Zeus Scientific Inc received FDA authorization to use the Dynex Agility, Dynex DSX, or Dynex DS2 Automated ELISA Systems to run the ZEUS ELISA SARS-SoV-2 total antibody test system. Hence, this led to a surge in demand for ELISA analyzers during the pandemic.
However, the ELISA analyzer market also experienced a negative impact during the COVID-19 pandemic as the volume of other infectious disorders such as HIV was reduced. For instance, according to the Minnesota Department of Health, the COVID-19 pandemic resulted in disruptions of HIV testing in Minnesota, United States in the year 2020. Also, according to the Centers for Disease Control and Prevention (CDC), new HIV diagnoses reported to CDC between 2019 to 2020 registered a decline of 17%. Furthermore, it also stated a substantial decline in HIV testing from 2019 to 2020.
In addition, access to clinical services and non-essential laboratory testing for diseases such as dengue, Lyme disease, and others also impacted during the pandemic. This was mainly because the testing laboratories worldwide were preoccupied with COVID-19 testing in the initial phase of the outbreak. For instance, Boston Medical Center published a press release in December 2020. According to this press release, new research from Boston Medical Center reported that decreased in-person hospital visits in the COVID-19 pandemic resulted in a decline in hospital-wide Hepatitis C (HCV) testing by 50%. Furthermore, the research also reported a decrease in new HCV diagnoses by more than 60%. Hence, the worldwide decline in ELISA testing during the pandemic lead to a decline in the demand for ELISA analyzers.
The major factor that leads to the growth of the studied market includes the widespread prevalence of infectious diseases and cancer. Furthermore, other factors such as the rise in demand for automated and portable ELISA systems also drive the growth of the market.
The surge in the prevalence of infectious diseases leads to a rise in demand for ELISA analyzers. For instance, according to an estimate by the World Health Organization (WHO), an estimated 38.4 million people were living with HIV at the end of 2021. Similarly, as of August 2022, the WHO Pan American Health Organization (PAHO) reported 2,141,240 dengue cases in the Americas. Thus, the surge in infectious disease led to a surge in ELSIA testing which in turn led to a surge in demand for ELISA analyzers thereby driving the growth of the market.
Furthermore, ELISA is employed to quantify antibody titers which are used for the evaluation of immunogenicity during vaccine development. Hence, the rise in vaccine development activities across the globe leads to a surge in demand for ELISA analyzers thereby driving the growth of the market. For instance, according to a review by the World Health Organization (WHO), in 2021 there were 112 bacterial vaccine candidates present in the clinical stage of development. Similarly, there were 109 bacterial vaccine candidates present in the preclinical stage of development.
In addition, pharmaceutical companies such as GSK plc. and Sanofi have a substantial number of vaccine candidates in the pipeline. For instance, Sanofi has 10 vaccine candidates in its pipeline according to the latest updates at the Q2 2022 results meeting, which was held in July 2022. Hence, the surge in vaccine developmental activities leads to a rise in demand for ELISA analyzers thereby driving the growth of the market. Howerver, lack of skilled professionals & low detection limit of existing technology is expected to hinder the market growth during the study period.
ELISA Analyzer Market Trends
This section covers the major market trends shaping the ELISA Analyzer Market according to our research experts:
Automated ELISA Analyzers are Expected to Witness High Growth Over the Forecast Period
Automated ELISA analyzers have various advantages over semi-automated ELISA analyzers. Thus, this makes them a preferred choice in testing laboratories. For instance, automation provides the possibility of a walk-away workflow that saves time. Furthermore, other benefits of automated ELISA analyzers include increased accuracy in results, cost efficiency, and fast turnaround times.
In addition, automation also provides an increase in flexibility. For instance, with the help of software and robotic component, automated analyzers can turn into a flexible workstation that can easily adapt to the required application. Hence, these benefits lead to a surge in their demand thereby driving the growth of the segment.
Other factors such as the high cost of automated ELISA analyzers are another factor that leads to a surge in revenues generated in the segment. In addition, key companies operating in the market are adopting strategies to provide advanced automated ELISA analyzers. This in turn leads to a surge in demand for automated analyzers thereby driving the growth of the segment. For instance, in August 2021, Novatec Immundiagnostica GmbH and Virotech Diagnostics GmbH merged with Gold Standard Diagnostics Inc. Furthermore, Gold Standard Diagnostics provides its ELISA automated analyzers through Novatec Immundiagnostica GmbH. Hence these factors drive the growth of the segment.
North America is Expected to Dominate the ELISA Analyzer Market
North America is expected to dominate the market. This is due to the surge in the prevalence of infectious diseases such as HIV, Lyme disease, hepatitis C and others that require ELISA testing. For instance, FAIR Health released a study in August 2022. The study claimed a substantial rise in Lyme disease diagnoses between 2007 to 2021 in both rural and urban areas in the United States. Furthermore, the results of the study indicated that private insurance claims associated with Lyme disease diagnoses increased by 357% in rural areas and 65% in urban areas.
Similarly, according to preliminary data reported by the Centers for Disease Control and Prevention (CDC), there were 101,590 cases of syphilis in 2017 in the United States which reached 171,074 cases of syphilis in 2021. Thus, the surge in prevalence of infectious diseases in the region leads to a surge in demand for ELISA analyzers thereby driving the growth of the market.
Furthermore, factors such as the presence of key players in the region lead to the easy availability of advanced automated ELISA analyzers which in turn contributes to the growth of the market. Some of the key players operating in the region include PerkinElmer Inc. (EUROIMMUN Medizinische Labordiagnostika AG), Eurofins Scientific (Eurofins Abraxis), Gold Standard Diagnostics Inc. (NovaTec Immundiagnostica GmbH), and Awareness Technology, Inc. Therefore, owing to the previously mentioned factors the growth of the market studied is anticipated in the North America Region.
ELISA Analyzer Industry Overview
The ELISA analyzer market is consolidated in nature due to the presence of a limited number of companies operating across the globe. The competitive landscape includes an analysis of a few international as well as local companies that operate in the market such as Dynex Technologies Inc, Berthold Technologies GmbH & Co.KG, Grifols, S.A., Eurofins Scientific (Eurofins Abraxis), PerkinElmer Inc. (EUROIMMUN Medizinische Labordiagnostika AG), Hamilton Company, BIOLINE Medical System, Gold Standard Diagnostics Inc. (NovaTec Immundiagnostica GmbH), Awareness Technology, Inc., and Everex S.r.l. among others.
ELISA Analyzer Market Leaders
-
Dynex Technologies Inc
-
Berthold Technologies GmbH & Co.KG
-
Grifols, S.A.
-
Eurofins Scientific (Eurofins Abraxis)
-
PerkinElmer Inc. (EUROIMMUN Medizinische Labordiagnostika AG)
*Disclaimer: Major Players sorted in no particular order
ELISA Analyzer Market News
- In May 2022, Molecular Devices, LLC., a provider of life science solutions launched five ready-made work cells for automated enzyme-linked immunosorbent assay (ELISA) workflows. In addition, through the launch company aims at providing advanced automation for the labor-intensive ELISA technique.
- In August 2021, Gold Standard Diagnostics Inc. merged with Novatec Immundiagnostica GmbH and Virotech Diagnostics GmbH. Furthermore, through this merger, Gold Standard Diagnostics expanded its product portfolio by including ELISA automated analyzers offered by Novatec Immundiagnostica GmbH.
ELISA Analyzer Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Incidence of Infectious Diseases
- 4.2.2 Rising Demand for Automated and Portable ELISA Systems
-
4.3 Market Restraints
- 4.3.1 Lack of Skilled Professionals & Low detection Limit of Existing Technology
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Type of Operation
- 5.1.1 Automated ELISA Analyzer
- 5.1.2 Semi-Automated Analyzer
-
5.2 By Modality
- 5.2.1 Bench Top
- 5.2.2 Stand Alone
-
5.3 By Application
- 5.3.1 Vaccines Development
- 5.3.2 Immunology
- 5.3.3 Drug Monitoring and Pharmaceutical Industry
- 5.3.4 Others
-
5.4 By End User
- 5.4.1 Diagnostic Laboratories
- 5.4.2 Pharmaceutical and Biotechnology Companies
- 5.4.3 Contract Research Organizations
- 5.4.4 Others
-
5.5 Geography
- 5.5.1 North America
- 5.5.1.1 United States
- 5.5.1.2 Canada
- 5.5.1.3 Mexico
- 5.5.2 Europe
- 5.5.2.1 Germany
- 5.5.2.2 United Kingdom
- 5.5.2.3 France
- 5.5.2.4 Italy
- 5.5.2.5 Spain
- 5.5.2.6 Rest of Europe
- 5.5.3 Asia-Pacific
- 5.5.3.1 China
- 5.5.3.2 Japan
- 5.5.3.3 India
- 5.5.3.4 Australia
- 5.5.3.5 South Korea
- 5.5.3.6 Rest of Asia-Pacific
- 5.5.4 Rest of the World
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Dynex Technologies Inc
- 6.1.2 Berthold Technologies GmbH & Co.KG
- 6.1.3 Grifols, S.A.
- 6.1.4 Eurofins Scientific (Eurofins Abraxis)
- 6.1.5 PerkinElmer Inc. (EUROIMMUN Medizinische Labordiagnostika AG)
- 6.1.6 Hamilton Company
- 6.1.7 BIOLINE Medical System
- 6.1.8 Gold Standard Diagnostics Inc. (NovaTec Immundiagnostica GmbH)
- 6.1.9 Awareness Technology, Inc.
- 6.1.10 Everex S.r.l.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityELISA Analyzer Industry Segmentation
As per the scope of the report, ELISA analyzers analytical instruments that perform a basic function that is needed to process an ELISA. These functions include reagent dispensing, microplate washing, incubation, and absorbance measurement. The ELISA analyzers market is segmented by Type of Operation (Automated ELISA Analyzer, and Semi-Automated Analyzer), Modality (Bench-Top, and Stand-Alone), Application (Vaccines Development, Immunology, Drug Monitoring and Pharmaceutical Industry, and Others), End User (Diagnostic Laboratories, Pharmaceutical, and Biotechnology Companies, Contract Research Organizations, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World). The report offers the value (in USD million) for the above segments.
| By Type of Operation | Automated ELISA Analyzer | |
| Semi-Automated Analyzer | ||
| By Modality | Bench Top | |
| Stand Alone | ||
| By Application | Vaccines Development | |
| Immunology | ||
| Drug Monitoring and Pharmaceutical Industry | ||
| Others | ||
| By End User | Diagnostic Laboratories | |
| Pharmaceutical and Biotechnology Companies | ||
| Contract Research Organizations | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Rest of the World |
ELISA Analyzer Market Research FAQs
What is the current Global ELISA Analyzer Market size?
The Global ELISA Analyzer Market is projected to register a CAGR of 2.30% during the forecast period (2024-2029)
Who are the key players in Global ELISA Analyzer Market?
Dynex Technologies Inc, Berthold Technologies GmbH & Co.KG, Grifols, S.A., Eurofins Scientific (Eurofins Abraxis) and PerkinElmer Inc. (EUROIMMUN Medizinische Labordiagnostika AG) are the major companies operating in the Global ELISA Analyzer Market.
Which is the fastest growing region in Global ELISA Analyzer Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global ELISA Analyzer Market?
In 2024, the North America accounts for the largest market share in Global ELISA Analyzer Market.
What years does this Global ELISA Analyzer Market cover?
The report covers the Global ELISA Analyzer Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global ELISA Analyzer Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Global ELISA Analyzer Industry Report
Statistics for the 2024 Global ELISA Analyzer market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global ELISA Analyzer analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
